3 completed, 1 suspended. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Suspended 1 |
| Phase 2 | 3 | Completed 2, Suspended 1 |
Follow ABTL0812: new trials by email Literature Review of ABTL0812 trials Research Report on ABTL0812
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study ABTL0812, Folfirinox, Placebo - Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Ability Pharmaceuticals SL | 150 | 2021-05-06 | 2024-03-18 |
| A Study of ABTL0812 in Pancreatic Cancer ABTL0812, Gemcitabine and nab-paclitaxel - Pancreatic Cancer | Phase 1 / Phase 2 | Suspended | Ability Pharmaceuticals SL | 60 | 2021-04-26 | 2025-10-01 |
| A Study to Assess the Efficacy and Safety of ABTL0812 ABTL0812 in combination with paclitaxel and carboplatin - Endometrial Cancer, Squamous Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Ability Pharmaceuticals SL | 103 | 2016-12-01 | 2023-02-22 |
| Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients ABTL0812 - Cancer | Phase 1 | Completed | Ability Pharmaceuticals SL | 27 | 2014-02-01 | 2015-07-02 |
Pancreatic Neoplasms (2) · Endometrial Neoplasms (1) · Neoplasms (1)
Ability Pharmaceuticals SL (4)
Spain (4) · France (1) · Israel (1) · United States (1)
Ana Oaknin (1) · Laura Vidal, MD, PhD (1) · Marc Cortal (1)
PMID 35293148, PMID 33588149, PMID 39039449
2016 (1)